Wednesday, February 10, 2010, 8:57am EST - Canadian Markets open in 33 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

AstraZeneca plc (AZN)

 On Feb 9: 44.11 USD   0.00 (0.00%)  
MORE ON AZN
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
ASTRAZENECA PLC ADS (NYSE:AZN) Delayed quote dataEdit
Pre-Market: 44.17 Up 0.06 (0.14%) as of 8:11am EST on 02/10/10
Last Trade: 44.11 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 44.11
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 50.39
Day's Range: N/A - N/A
52wk Range: 29.96 - 50.70
Volume: 200
Avg Vol (3m): 1,465,750
Market Cap: 64.00B
P/E (ttm): 8.50
EPS (ttm): 5.19
Div & Yield: 2.30 (5.21%)
AstraZeneca plc (AZN)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add AZN to Portfolio   Download Data

HEADLINES
• Biotech Stocks: Cell Therapeutics, AstraZeneca lead drug stocks
at MarketWatch (Tue 1:31pm)
• AstraZeneca Goes to the Well One Last Time
at Minyanville.com (Tue 12:50pm)
• Label Expansion for AZN Drug
Zacks.com (Tue 11:53am)
• Rewriting AstraZeneca's Script
at CNBC (Tue 11:31am)
• Europe Launches Probe into Pharma Deals
at BusinessWeek (Tue 10:52am)
• Biotech Stocks: Drug stocks gain; Cell Therapeutics rebounds
at MarketWatch (Tue 10:23am)
• Cholesterol Drug Approved for People Without High Cholesterol
at The Wall Street Journal Online (Tue 8:53am)
• [$$] Wider FDA Approval Could Boost Crestor Sales
at The Wall Street Journal Online (Tue 8:27am)
• [$$] Great Off-the-Radar Stocks
at Barrons.com (Tue 6:00am)
• AstraZeneca says FDA approves Crestor indication
at MarketWatch (Tue 2:21am)
• Crestor Wins Approval as a Drug to Prevent Heart Disease
at The New York Times (Tue 12:04am)
• US FDA Approves New Indication for CRESTOR(R) (rosuvastatin calcium)
PRNewswire (Mon, Feb 8)
• AstraZeneca gets OK for expanded Crestor use
AP (Mon, Feb 8)
More Headlines for AZN...
ANALYST
EPS Est (next year) (Dec-10) : 5.94
EPS Est (in 2 years) (Dec-11) : 5.94
Avg Rec (current)*: 3.2
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
AstraZeneca plc discovers, develops, manufactures, and markets prescription pharmaceuticals and biological products in the areas of cardiovascular, gastrointestinal, neuroscience, oncology, respiratory and inflammation, and infection worldwide.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices